Time-dependent neurovascular unit dysfunction in ischemic stroke: mechanisms of neurovascular uncoupling and its clinical impact
Top Cited Papers
- 10 February 2026
- journal article
- review article
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 136 (6) , 733-744
Abstract
Neurovascular unit (NVU) dysfunction is a central determinant of tissue injury, reperfusion failure, and long-term neurological outcomes after ischemic stroke. This review critically examines the cellular and molecular mechanisms underlying NVU disruption, with a particular focus on inflammation, oxidative stress, and blood-brain barrier (BBB) integrity, and evaluates emerging NVU-targeted therapeutic strategies. A focused narrative review synthesized studies on ischemic stroke-related NVU alterations, integrating cellular mechanisms, biomarkers, and phase-specific therapeutic strategies targeting BBB dysfunction, inflammation, oxidative stress, and neurorestoration. Acute ischemic injury induces endothelial tight-junction disruption, pericyte constriction and loss, astrocytic activation, and microglial-driven inflammation, resulting in BBB breakdown, impaired neurovascular coupling, and restricted microvascular reperfusion. These processes facilitate leukocyte infiltration, exacerbate secondary neuronal damage, and increase hemorrhagic transformation risk. Circulating and cerebrospinal fluid biomarkers, including MMP-9, GFAP, S100B, and pro-inflammatory cytokines, reflect NVU injury severity and correlate with functional outcomes. In the chronic phase, persistent BBB permeability, maladaptive VEGF signaling, and sustained low-grade inflammation contribute to white matter injury, impaired neuroplasticity, and post-stroke cognitive decline. Therapeutic strategies targeting NVU dysfunction include anti-inflammatory agents, COX-2 inhibitors, and NADPH oxidase inhibitors, alongside stem cell-based and extracellular vesicle-mediated approaches that promote vascular stabilization and repair. Neuroplasticity-enhancing interventions and nanoparticle-based drug delivery systems further support functional recovery. NVU dysfunction underlies both acute injury amplification and chronic recovery failure after stroke. Biomarker-guided, phase-specific therapeutic strategies targeting inflammation, oxidative stress, and BBB instability represent a promising framework for personalized stroke management.Keywords
This publication has 96 references indexed in Scilit:
- Bloodstream Infection-induced Neuroinflammation: from Systemic Infection To Brain InvasionCurrent Microbiology, 2025
- Biomarkers of blood–brain barrier and neurovascular unit integrity in human cognitive impairment and dementiaAlzheimer's & Dementia, 2025
- Nelonemdaz and Patients With Acute Ischemic Stroke and Mechanical ReperfusionJAMA Network Open, 2025
- Drivers of Chronic Pathology Following Ischemic Stroke: A Descriptive ReviewCellular and Molecular Neurobiology, 2023
- Neuroinflammation in Acute Ischemic and Hemorrhagic StrokeCurrent Neurology and Neuroscience Reports, 2023
- Biology and function of pericytes in the vascular microcirculationAnimal Models and Experimental Medicine, 2023
- Engineering Neurovascular Unit and Blood–Brain Barrier for Ischemic Stroke ModelingAdvanced Healthcare Materials, 2023
- A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluidAlzheimer's & Dementia, 2020
- Pericytes in Brain Injury and Repair After Ischemic StrokeTranslational Stroke Research, 2016
- Monitoring tissue oxygenation by near infrared spectroscopy (NIRS): background and current applicationsJournal of Clinical Monitoring and Computing, 2012